Acorda Therapeutics (NQ: ACOR )
0.6000 -0.0200 (-3.23%) Streaming Delayed Price Updated: 11:56 AM EDT, Mar 22, 2023 Add to My Watchlist
All News about Acorda Therapeutics
John Varian Joins Acorda Therapeutics Board of Directors
January 03, 2022
Acorda Inks Distribution Pact In Germany For Inhaled Levodopa Powder; Q3 Earnings Beat Expectations
November 10, 2021
Acorda Therapeutics Inc (NASDAQ: ACOR) entered into distribution and supply agreements with Esteve Pharmaceuticals GmbH to commercialize Inbrija 33 mg (...
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
November 02, 2021
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
September 09, 2021
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
July 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following